Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications.
about
Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritolReactive Oxygen Species: A Key Hallmark of Cardiovascular DiseaseRedox Roles of Reactive Oxygen Species in Cardiovascular DiseasesCardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in ratsThe role of lipotoxicity in smoke cardiomyopathyMangiferin modulation of metabolism and metabolic syndrome.Relationship between antioxidant capacity and oxidative stress in children with acute hepatitis A.Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis.Emerging therapeutic targets in nitric oxide-dependent cardiac disease.Vascular NAD(P)H oxidases: specific features, expression, and regulation.Clinical pharmacology and therapeutic use of antioxidant vitamins.Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology.Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathwayKorean Red Ginseng Induced Cardioprotection against Myocardial Ischemia in Guinea Pig.Xanthine oxidoreductase in respiratory and cardiovascular disorders.Green tea catechins and cardiovascular health: an update.Total antioxidant performance is associated with diet and serum antioxidants in participants of the diet and physical activity substudy of the Jackson Heart StudyCardioprotective effects of angiotensin III against ischemic injury via the AT2 receptor and KATP channels.Increased myocardial prevalence of C-reactive protein in human coronary heart disease: direct effects on microvessel density and endothelial cell survivalChinese medicinal formula Guanxin Shutong capsule protects the heart against oxidative stress and apoptosis induced by ischemic myocardial injury in rats.Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in miceAngiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: Role of ROS and NF-κB.Protective effects of Eruca sativa (rocket) on abamectin insecticide toxicity in male albino rats.The protective effect of rutin against ischemia/reperfusion-associated hemodynamic alteration through antioxidant activity.Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review.Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: Roles of Nrf2/HO-1 and PI3K/Akt pathway.Development and validation of an algorithm to establish a total antioxidant capacity database of the US diet.Antioxidants and phase 2 enzymes in cardiomyocytes: Chemical inducibility and chemoprotection against oxidant and simulated ischemia-reperfusion injury.Xanthine Oxidase Inhibitor, Allopurinol, Prevented Oxidative Stress, Fibrosis, and Myocardial Damage in Isoproterenol Induced Aged Rats.Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury.Combined Effects of Vincristine and Quercetin in Reducing Isoproterenol-Induced Cardiac Necrosis in Rats.Cardioprotective effect of Nerium oleander flower against isoproterenol-induced myocardial oxidative stress in experimental rats.Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.).The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.Melatonin protects myocardium from ischemia-reperfusion injury in hypertensive rats: role of myeloperoxidase activity.AIDS-related vasculopathy: evidence for oxidative and inflammatory pathways in murine and human AIDS.Mechanisms for suppressing NADPH oxidase in the vascular wall.Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins.Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects.Nitric oxide synthase inhibition in rats: melatonin reduces blood pressure and ischemia/reperfusion-induced infarct size.
P2860
Q21133022-07B56275-13FD-494F-99E4-6AFEB1D82765Q28076240-3867C7B9-7A1B-4675-8E24-14F4328B7C9DQ28082072-38EB7C16-F3C6-4C8E-AF1B-A3E471A329A1Q28484893-19DF8B2C-A620-44E6-BDA6-02CF7B0C59F8Q28542446-F55F58DC-C6D5-4E2A-A025-0FF7CF10C063Q30244206-8501BCC3-16FF-446E-98E1-7236E3D2B9ACQ33869040-CE50E360-2A7B-444D-B654-68EA27C306E5Q34427722-F3A5D701-10EB-45BD-ABFC-13BEC20176C2Q35050418-D6A8D8D5-5DFE-4450-ABB4-F3B7049A6DD8Q35175526-C7553ABC-3D2B-496E-AFC8-5290FA47A9EBQ36772931-7C2AD2CC-F0E5-4109-BB09-D36C4407D018Q36828341-1D29085E-B927-411E-82FA-63EDF435B049Q36983754-8D3FF3AE-7959-4213-98F9-3D76900474DEQ37090085-6F91D12E-D7F8-4F26-82E8-5DE540CEEEBAQ37111434-BE3BDC7E-6D2E-4F42-80E0-E0B60D9D0CA3Q37239682-C194CBB4-0B4A-4534-82A4-C079034A7C30Q37348362-ABDA4350-F63E-4E3D-A471-08529F328E79Q37411088-61F48AFA-26EF-4F14-BB97-B82E4DA65AB2Q37507544-2DAC80EB-3ED8-49F5-870A-AAB5436C4867Q37662098-A4AF6F84-1B33-4C3F-9F6E-4B0A126F00E3Q37688764-897E7031-C984-4AFC-9DBC-D3A8C6EA498CQ38848847-AF97D99A-B9DE-4714-8002-0CDFDD4558E6Q39243104-85303D24-C791-49A2-BCFF-72C332ECC2CAQ39301165-B538B15D-2B7A-4922-ACC4-75A732B33D10Q39323874-2423C850-B8A5-4A53-8FCA-2A4987AF48C1Q39593029-8B879405-F32A-4D4A-B9E7-3C810B345936Q39884722-4DEB63E9-A09A-4F4C-9CA6-63CCCCC7F128Q40237280-86AF2707-8C2F-4648-852A-61CD75EE6AC6Q42414700-6C6B1C13-82F6-4125-A760-96C3E9B4FD6DQ42478374-A65633CA-33BC-4186-A2EE-8A708C851839Q42703092-DBBA1B7C-E1BE-4385-BB01-CB25F11DA4A1Q42770145-6B2B9804-3886-429A-BD9F-F13D1D6380B2Q43244892-42F1D10D-F899-4D06-AF42-4C2B2E6A6DB6Q44720807-D86E4CAA-5934-488C-8DAD-8D228CD1AAECQ46316554-123DD69D-3FA3-4D89-AA75-E9FA12416486Q46516441-5FDE0B97-0E8C-4EEC-9BD0-7C7068FEDAD6Q46552044-12A6F8DB-D1E3-4DF5-B739-6037210F347CQ46553606-00A60A17-DAE0-49C0-9207-9D9CB739BE80Q46563642-C46B97F1-3BAC-4B11-91CD-2EEFA712CB15Q47325273-61C7D3E8-DB1B-4013-9C3A-1091E269598C
P2860
Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oxidative pathways in cardiova ...... and therapeutic implications.
@ast
Oxidative pathways in cardiova ...... and therapeutic implications.
@en
Oxidative pathways in cardiova ...... and therapeutic implications.
@nl
type
label
Oxidative pathways in cardiova ...... and therapeutic implications.
@ast
Oxidative pathways in cardiova ...... and therapeutic implications.
@en
Oxidative pathways in cardiova ...... and therapeutic implications.
@nl
prefLabel
Oxidative pathways in cardiova ...... and therapeutic implications.
@ast
Oxidative pathways in cardiova ...... and therapeutic implications.
@en
Oxidative pathways in cardiova ...... and therapeutic implications.
@nl
P1476
Oxidative pathways in cardiova ...... and therapeutic implications.
@en
P2093
Wattanapitayakul SK
P304
P356
10.1016/S0163-7258(00)00114-5
P577
2001-02-01T00:00:00Z